Paul Allen’s $5m Ebola project helped bring 14 Covid-infected Americans home
A biocontainment system funded by the late Paul Allen after the 2014 Ebola outbreak proved vital during the early COVID-19 pandemic. The technology allowed for the safe transport of infected Americans from a cruise ship in Japan to the US.
Why it matters
It demonstrates the long-term impact of private philanthropic investment in medical infrastructure and pandemic preparedness.
A medical evacuation technology backed by late Microsoft co-founder Paul Allen after the 2014 Ebola outbreak went on to play a crucial role during the early days of the Covid-19 pandemic, helping safely transport infected Americans from a quarantined cruise ship in Japan. Following the Ebola crisis in West Africa, Allen provided $5 million in funding to support the development of advanced biocontainment capabilities that could safely move patients infected with highly contagious diseases. The project led to the creation of specialised isolation systems designed to protect both patients and medical personnel during transport.From Ebola to coronavirusThe technology called Containerized Biocontainment System (CBCS) was developed by Kansas City-based biocontainment and global health engineering firm MRIGlobal with the help of a public-private partnership with the US Department of State and the Paul G. Allen Foundation, created in direct response to the 2014 West African Ebola outbreak.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in